Related Experiment Video

Updated: Jul 5, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

[Progression of coronary disease: minutes, weeks, decades...]

S Weber1

  • 1Hôpital Cochin, AP-HP, 27, rue Faubourg St Jacques, 75014 Paris, France. simon.weber@cch.aphp.fr

Annales De Cardiologie Et D'Angeiologie
|June 18, 2008
PubMed

Insights

Coronary atheroma progresses slowly, often without symptoms due to arterial remodeling. Plaque rupture causes thrombus formation, leading to varied clinical events, manageable with statins and platelet inhibitors.

Area of Science:

  • Cardiovascular Medicine
  • Pathophysiology
  • Pharmacology

Context:

  • Coronary artery disease (CAD) pathogenesis involves slow atheroma progression.
  • Arterial remodeling and collateral circulation can mask early CAD.
  • Unstable plaque rupture is a critical event leading to thrombus formation.

Purpose:

  • To explain the pathophysiology of coronary artery disease and its clinical manifestations.
  • To highlight the role of plaque rupture and thrombus formation in CAD severity.
  • To discuss the primary and secondary treatment strategies for coronary artery disease.

Summary:

  • Coronary atheroma develops over decades, often compensated by arterial remodeling and collateral circulation, leading to asymptomatic disease.
  • Sudden rupture of unstable atheromatous plaque triggers endovascular thrombus formation, determining clinical outcomes from angina to myocardial infarction or sudden death.
  • Statins and platelet inhibitors are crucial for reducing plaque rupture probability and severity in all CAD cases.

Impact:

  • Understanding CAD progression and rupture dynamics is key for timely intervention.
  • Early use of statins and platelet inhibitors can significantly mitigate adverse cardiovascular events.
  • Tailored therapeutic approaches, including anti-ischemic drugs and revascularization, are essential for individualized patient management.

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...